181 related articles for article (PubMed ID: 32931337)
1. Genetic Loss of
Reilly L; Alvarado FJ; Lang D; Abozeid S; Van Ert H; Spellman C; Warden J; Makielski JC; Glukhov AV; Eckhardt LL
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008638. PubMed ID: 32931337
[TBL] [Abstract][Full Text] [Related]
2. KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia.
Kalscheur MM; Vaidyanathan R; Orland KM; Abozeid S; Fabry N; Maginot KR; January CT; Makielski JC; Eckhardt LL
Heart Rhythm; 2014 May; 11(5):885-94. PubMed ID: 24561538
[TBL] [Abstract][Full Text] [Related]
3. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
[TBL] [Abstract][Full Text] [Related]
4. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Neco P; Torrente AG; Mesirca P; Zorio E; Liu N; Priori SG; Napolitano C; Richard S; Benitah JP; Mangoni ME; Gómez AM
Circulation; 2012 Jul; 126(4):392-401. PubMed ID: 22711277
[TBL] [Abstract][Full Text] [Related]
6. Late I
Hwang J; Kim TY; Terentyev D; Zhong M; Kabakov AY; Bronk P; Arunachalam K; Belardinelli L; Rajamani S; Kunitomo Y; Pfeiffer Z; Lu Y; Peng X; Odening KE; Qu Z; Karma A; Koren G; Choi BR
Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e006875. PubMed ID: 32628505
[TBL] [Abstract][Full Text] [Related]
7. Dyscholesterolemia Protects Against Ischemia-Induced Ventricular Arrhythmias.
Baartscheer A; Schumacher CA; Wekker V; Verkerk AO; Veldkamp MW; van Oort RJ; Elzenaar I; Ottenhoff R; van Roomen C; Aerts H; Coronel R
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1481-90. PubMed ID: 26429563
[TBL] [Abstract][Full Text] [Related]
8. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
[TBL] [Abstract][Full Text] [Related]
9. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.
van den Hoogenhof MMG; Beqqali A; Amin AS; van der Made I; Aufiero S; Khan MAF; Schumacher CA; Jansweijer JA; van Spaendonck-Zwarts KY; Remme CA; Backs J; Verkerk AO; Baartscheer A; Pinto YM; Creemers EE
Circulation; 2018 Sep; 138(13):1330-1342. PubMed ID: 29650543
[TBL] [Abstract][Full Text] [Related]
10. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
11. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
[TBL] [Abstract][Full Text] [Related]
12. Complex Arrhythmia Syndrome in a Knock-In Mouse Model Carrier of the N98S
Tsai WC; Guo S; Olaopa MA; Field LJ; Yang J; Shen C; Chang CP; Chen PS; Rubart M
Circulation; 2020 Nov; 142(20):1937-1955. PubMed ID: 32929985
[TBL] [Abstract][Full Text] [Related]
13. Decreased inward rectifying K+ current and increased ryanodine receptor sensitivity synergistically contribute to sustained focal arrhythmia in the intact rabbit heart.
Myles RC; Wang L; Bers DM; Ripplinger CM
J Physiol; 2015 Mar; 593(6):1479-93. PubMed ID: 25772297
[TBL] [Abstract][Full Text] [Related]
14. Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility.
Hegyi B; Ko CY; Bossuyt J; Bers DM
Cardiovasc Res; 2021 Dec; 117(14):2781-2793. PubMed ID: 33483728
[TBL] [Abstract][Full Text] [Related]
15. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
[TBL] [Abstract][Full Text] [Related]
16. KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.
Eckhardt LL; Farley AL; Rodriguez E; Ruwaldt K; Hammill D; Tester DJ; Ackerman MJ; Makielski JC
Heart Rhythm; 2007 Mar; 4(3):323-9. PubMed ID: 17341397
[TBL] [Abstract][Full Text] [Related]
17. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
[TBL] [Abstract][Full Text] [Related]
18. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Dirksen WP; Lacombe VA; Chi M; Kalyanasundaram A; Viatchenko-Karpinski S; Terentyev D; Zhou Z; Vedamoorthyrao S; Li N; Chiamvimonvat N; Carnes CA; Franzini-Armstrong C; Györke S; Periasamy M
Cardiovasc Res; 2007 Jul; 75(1):69-78. PubMed ID: 17449018
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heart.
Trum M; Islam MMT; Lebek S; Baier M; Hegner P; Eaton P; Maier LS; Wagner S
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1347-H1357. PubMed ID: 33035439
[TBL] [Abstract][Full Text] [Related]
20. Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography.
Paavola J; Väänänen H; Larsson K; Penttinen K; Toivonen L; Kontula K; Laine M; Aalto-Setälä K; Swan H; Viitasalo M
Europace; 2016 Oct; 18(10):1599-1607. PubMed ID: 26705554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
